American Journal of Obstetrics & Gynecology
Volume 199, Issue 1 , Pages 32.e1-32.e5, July 2008

Higher maximum doses of oxytocin are associated with an unacceptably high risk for uterine rupture in patients attempting vaginal birth after cesarean delivery

Presented at the 28th Annual Meeting of the Society for Maternal-Fetal Medicine, Dallas, TX, Jan. 28 to Feb. 2, 2008.

  • Alison G. Cahill, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO
  • ,
  • Brian M. Waterman, MPH

      Affiliations

    • Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • ,
  • David M. Stamilio, MD, MSCE

      Affiliations

    • Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO
  • ,
  • Anthony O. Odibo, MD, MSCE

      Affiliations

    • Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO
  • ,
  • Jenifer E. Allsworth, PhD

      Affiliations

    • Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO
  • ,
  • Bradley Evanoff, MD, MPH

      Affiliations

    • Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  • ,
  • George A. Macones, MD, MSCE

      Affiliations

    • Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO

Received 26 September 2007; received in revised form 18 December 2007; accepted 3 March 2008. published online 06 May 2008.

Objective

The objective of the study was to more precisely estimate the effect of maximum oxytocin dose on uterine rupture risk in patients attempting vaginal birth after cesarean (VBAC) by considering timing and duration of therapy.

Study Design

A nested case-control study was conducted within a multicenter, retrospective cohort study of more than 25,000 women with at least 1 prior cesarean delivery, comparing cases of uterine rupture with controls (no rupture) while attempting VBAC. Time-to-event analyses were performed to examine the effect of maximum oxytocin dose on the risk of uterine rupture considering therapy duration, while adjusting for confounders.

Results

Within the nested case-control study of 804 patients, 272 were exposed to oxytocin: 62 cases of uterine rupture and 210 controls. Maximum oxytocin ranges above 20 mU/min increased the risk of uterine rupture 4-fold or greater (21-30 mU/min: hazard ratio [HR] 3.92, 95% confidence interval [CI], 1.06 to 14.52; 31-40 mU/min: HR 4.57, 95% CI, 1.00 to 20.82).

Conclusion

These findings support a maximum oxytocin dose of 20 mU/min in VBAC trials to avoid an unacceptably high risk of uterine rupture.

Key words: oxytocin, uterine rupture, vaginal birth after cesarean

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Cite this article as: Cahill AG, Waterman BM, Stamilio DM, et al. Higher maximum doses of oxytocin are associated with an unacceptably high risk for uterine rupture in patients attempting vaginal birth after cesarean delivery. Am J Obstet Gynecol 2008;199:32.e1-32.e5.

 Reprints not available from the authors.

 This work was supported by Grants R01 HD 35631 and K24 HD01289, both from the National Institute of Child Health and Human Development (to G.A.M.).

PII: S0002-9378(08)00262-7

doi:10.1016/j.ajog.2008.03.001

American Journal of Obstetrics & Gynecology
Volume 199, Issue 1 , Pages 32.e1-32.e5, July 2008